nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—NOS2—focal segmental glomerulosclerosis	0.379	1	CbGaD
Doxorubicin—ABCC10—Cyclosporine—focal segmental glomerulosclerosis	0.124	0.3	CbGbCtD
Doxorubicin—ABCC3—Cyclosporine—focal segmental glomerulosclerosis	0.0783	0.188	CbGbCtD
Doxorubicin—ABCB11—Cyclosporine—focal segmental glomerulosclerosis	0.0677	0.163	CbGbCtD
Doxorubicin—ABCC1—Cyclosporine—focal segmental glomerulosclerosis	0.0481	0.116	CbGbCtD
Doxorubicin—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.0356	0.0856	CbGbCtD
Doxorubicin—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.0322	0.0774	CbGbCtD
Doxorubicin—NOS1—arteriole—focal segmental glomerulosclerosis	0.0131	0.167	CbGeAlD
Doxorubicin—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.0279	CbGbCtD
Doxorubicin—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0263	CbGbCtD
Doxorubicin—NOS3—arteriole—focal segmental glomerulosclerosis	0.00999	0.127	CbGeAlD
Doxorubicin—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.00695	0.0167	CbGbCtD
Doxorubicin—Heart sounds abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0059	0.0698	CcSEcCtD
Doxorubicin—Abnormal pigmentation—Cyclosporine—focal segmental glomerulosclerosis	0.00522	0.0617	CcSEcCtD
Doxorubicin—NOS3—nephron—focal segmental glomerulosclerosis	0.00435	0.0552	CbGeAlD
Doxorubicin—NOS1—endothelium—focal segmental glomerulosclerosis	0.0027	0.0342	CbGeAlD
Doxorubicin—SLC22A16—kidney—focal segmental glomerulosclerosis	0.00248	0.0314	CbGeAlD
Doxorubicin—Septicemia—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.0256	CcSEcCtD
Doxorubicin—NOS3—endothelium—focal segmental glomerulosclerosis	0.00205	0.026	CbGeAlD
Doxorubicin—ABCB8—kidney—focal segmental glomerulosclerosis	0.00193	0.0245	CbGeAlD
Doxorubicin—AKR1A1—nephron tubule—focal segmental glomerulosclerosis	0.00163	0.0207	CbGeAlD
Doxorubicin—Polyneuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.0179	CcSEcCtD
Doxorubicin—NDUFS7—nephron tubule—focal segmental glomerulosclerosis	0.00148	0.0188	CbGeAlD
Doxorubicin—Pigmentation disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.0174	CcSEcCtD
Doxorubicin—AKR1A1—kidney—focal segmental glomerulosclerosis	0.00143	0.0182	CbGeAlD
Doxorubicin—AKR1A1—cortex of kidney—focal segmental glomerulosclerosis	0.00139	0.0177	CbGeAlD
Doxorubicin—NDUFS7—kidney—focal segmental glomerulosclerosis	0.0013	0.0165	CbGeAlD
Doxorubicin—NDUFS7—cortex of kidney—focal segmental glomerulosclerosis	0.00127	0.0161	CbGeAlD
Doxorubicin—Bullous eruption—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.0147	CcSEcCtD
Doxorubicin—NDUFS2—nephron tubule—focal segmental glomerulosclerosis	0.00123	0.0156	CbGeAlD
Doxorubicin—NDUFS3—nephron tubule—focal segmental glomerulosclerosis	0.00121	0.0154	CbGeAlD
Doxorubicin—AURKA—kidney—focal segmental glomerulosclerosis	0.00121	0.0154	CbGeAlD
Doxorubicin—DHCR7—nephron tubule—focal segmental glomerulosclerosis	0.00115	0.0146	CbGeAlD
Doxorubicin—NOS1—kidney—focal segmental glomerulosclerosis	0.00108	0.0138	CbGeAlD
Doxorubicin—NDUFS2—kidney—focal segmental glomerulosclerosis	0.00108	0.0137	CbGeAlD
Doxorubicin—NDUFS3—kidney—focal segmental glomerulosclerosis	0.00106	0.0135	CbGeAlD
Doxorubicin—NOS1—cortex of kidney—focal segmental glomerulosclerosis	0.00106	0.0134	CbGeAlD
Doxorubicin—NDUFS2—cortex of kidney—focal segmental glomerulosclerosis	0.00105	0.0133	CbGeAlD
Doxorubicin—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.0124	CcSEcCtD
Doxorubicin—NDUFS3—cortex of kidney—focal segmental glomerulosclerosis	0.00104	0.0132	CbGeAlD
Doxorubicin—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.0119	CcSEcCtD
Doxorubicin—ABCC6—kidney—focal segmental glomerulosclerosis	0.000986	0.0125	CbGeAlD
Doxorubicin—DHCR7—cortex of kidney—focal segmental glomerulosclerosis	0.000985	0.0125	CbGeAlD
Doxorubicin—RALBP1—nephron tubule—focal segmental glomerulosclerosis	0.000954	0.0121	CbGeAlD
Doxorubicin—YWHAG—kidney—focal segmental glomerulosclerosis	0.000928	0.0118	CbGeAlD
Doxorubicin—XDH—kidney—focal segmental glomerulosclerosis	0.000905	0.0115	CbGeAlD
Doxorubicin—YWHAG—cortex of kidney—focal segmental glomerulosclerosis	0.000904	0.0115	CbGeAlD
Doxorubicin—CBR1—nephron tubule—focal segmental glomerulosclerosis	0.000891	0.0113	CbGeAlD
Doxorubicin—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.000889	0.0105	CcSEcCtD
Doxorubicin—AKR1C3—nephron tubule—focal segmental glomerulosclerosis	0.00088	0.0112	CbGeAlD
Doxorubicin—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.000867	0.0103	CcSEcCtD
Doxorubicin—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.000846	0.01	CcSEcCtD
Doxorubicin—RALBP1—kidney—focal segmental glomerulosclerosis	0.000838	0.0106	CbGeAlD
Doxorubicin—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000837	0.0099	CcSEcCtD
Doxorubicin—NOS3—kidney—focal segmental glomerulosclerosis	0.000825	0.0105	CbGeAlD
Doxorubicin—RALBP1—cortex of kidney—focal segmental glomerulosclerosis	0.000817	0.0104	CbGeAlD
Doxorubicin—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.000809	0.00957	CcSEcCtD
Doxorubicin—Polyp—Cyclosporine—focal segmental glomerulosclerosis	0.000809	0.00957	CcSEcCtD
Doxorubicin—POR—nephron tubule—focal segmental glomerulosclerosis	0.000803	0.0102	CbGeAlD
Doxorubicin—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0008	0.00946	CcSEcCtD
Doxorubicin—Optic neuritis—Cyclosporine—focal segmental glomerulosclerosis	0.0008	0.00946	CcSEcCtD
Doxorubicin—CBR1—kidney—focal segmental glomerulosclerosis	0.000783	0.00994	CbGeAlD
Doxorubicin—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.000783	0.00926	CcSEcCtD
Doxorubicin—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.000783	0.00926	CcSEcCtD
Doxorubicin—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000774	0.00916	CcSEcCtD
Doxorubicin—CBR1—cortex of kidney—focal segmental glomerulosclerosis	0.000762	0.00968	CbGeAlD
Doxorubicin—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000758	0.00897	CcSEcCtD
Doxorubicin—AKR1C3—cortex of kidney—focal segmental glomerulosclerosis	0.000753	0.00956	CbGeAlD
Doxorubicin—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.000736	0.00871	CcSEcCtD
Doxorubicin—NQO1—nephron tubule—focal segmental glomerulosclerosis	0.000714	0.00906	CbGeAlD
Doxorubicin—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.000708	0.00838	CcSEcCtD
Doxorubicin—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.000695	0.00822	CcSEcCtD
Doxorubicin—POR—cortex of kidney—focal segmental glomerulosclerosis	0.000687	0.00873	CbGeAlD
Doxorubicin—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000682	0.00808	CcSEcCtD
Doxorubicin—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.000653	0.00773	CcSEcCtD
Doxorubicin—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.000637	0.00754	CcSEcCtD
Doxorubicin—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.000632	0.00748	CcSEcCtD
Doxorubicin—NQO1—kidney—focal segmental glomerulosclerosis	0.000627	0.00796	CbGeAlD
Doxorubicin—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000627	0.00742	CcSEcCtD
Doxorubicin—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.000627	0.00742	CcSEcCtD
Doxorubicin—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000627	0.00742	CcSEcCtD
Doxorubicin—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.000622	0.00736	CcSEcCtD
Doxorubicin—NQO1—cortex of kidney—focal segmental glomerulosclerosis	0.000611	0.00775	CbGeAlD
Doxorubicin—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.000607	0.00718	CcSEcCtD
Doxorubicin—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.000603	0.00713	CcSEcCtD
Doxorubicin—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.000585	0.00692	CcSEcCtD
Doxorubicin—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.000576	0.00682	CcSEcCtD
Doxorubicin—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.000564	0.00667	CcSEcCtD
Doxorubicin—ABCC3—kidney—focal segmental glomerulosclerosis	0.000563	0.00715	CbGeAlD
Doxorubicin—ABCC10—kidney—focal segmental glomerulosclerosis	0.00056	0.00711	CbGeAlD
Doxorubicin—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00056	0.00662	CcSEcCtD
Doxorubicin—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00056	0.00662	CcSEcCtD
Doxorubicin—ABCC10—cortex of kidney—focal segmental glomerulosclerosis	0.000545	0.00692	CbGeAlD
Doxorubicin—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000545	0.00644	CcSEcCtD
Doxorubicin—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.000545	0.00644	CcSEcCtD
Doxorubicin—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.000541	0.0064	CcSEcCtD
Doxorubicin—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000541	0.0064	CcSEcCtD
Doxorubicin—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000541	0.0064	CcSEcCtD
Doxorubicin—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.000534	0.00632	CcSEcCtD
Doxorubicin—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.000534	0.00632	CcSEcCtD
Doxorubicin—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.000534	0.00632	CcSEcCtD
Doxorubicin—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00053	0.00627	CcSEcCtD
Doxorubicin—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00053	0.00627	CcSEcCtD
Doxorubicin—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000517	0.00611	CcSEcCtD
Doxorubicin—ABCC2—nephron tubule—focal segmental glomerulosclerosis	0.000512	0.0065	CbGeAlD
Doxorubicin—CYP1B1—nephron tubule—focal segmental glomerulosclerosis	0.000501	0.00636	CbGeAlD
Doxorubicin—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.000501	0.00593	CcSEcCtD
Doxorubicin—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.000492	0.00582	CcSEcCtD
Doxorubicin—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.000492	0.00582	CcSEcCtD
Doxorubicin—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000483	0.00572	CcSEcCtD
Doxorubicin—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.000483	0.00572	CcSEcCtD
Doxorubicin—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.000478	0.00565	CcSEcCtD
Doxorubicin—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00047	0.00556	CcSEcCtD
Doxorubicin—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.000467	0.00553	CcSEcCtD
Doxorubicin—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.000464	0.0055	CcSEcCtD
Doxorubicin—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000462	0.00546	CcSEcCtD
Doxorubicin—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.000452	0.00535	CcSEcCtD
Doxorubicin—ABCC2—kidney—focal segmental glomerulosclerosis	0.00045	0.00571	CbGeAlD
Doxorubicin—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00045	0.00532	CcSEcCtD
Doxorubicin—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00045	0.00532	CcSEcCtD
Doxorubicin—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.000445	0.00526	CcSEcCtD
Doxorubicin—CYP1B1—kidney—focal segmental glomerulosclerosis	0.00044	0.00559	CbGeAlD
Doxorubicin—ABCC2—cortex of kidney—focal segmental glomerulosclerosis	0.000438	0.00556	CbGeAlD
Doxorubicin—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.000429	0.00508	CcSEcCtD
Doxorubicin—CYP1B1—cortex of kidney—focal segmental glomerulosclerosis	0.000429	0.00545	CbGeAlD
Doxorubicin—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.000427	0.00505	CcSEcCtD
Doxorubicin—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.000427	0.00505	CcSEcCtD
Doxorubicin—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000419	0.00495	CcSEcCtD
Doxorubicin—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.000411	0.00486	CcSEcCtD
Doxorubicin—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000409	0.00483	CcSEcCtD
Doxorubicin—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000399	0.00472	CcSEcCtD
Doxorubicin—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.000397	0.0047	CcSEcCtD
Doxorubicin—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.000397	0.0047	CcSEcCtD
Doxorubicin—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.000396	0.00468	CcSEcCtD
Doxorubicin—ABCC1—cortex of kidney—focal segmental glomerulosclerosis	0.000386	0.0049	CbGeAlD
Doxorubicin—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.000382	0.00452	CcSEcCtD
Doxorubicin—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00038	0.0045	CcSEcCtD
Doxorubicin—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.000378	0.00448	CcSEcCtD
Doxorubicin—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000375	0.00444	CcSEcCtD
Doxorubicin—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.000374	0.00442	CcSEcCtD
Doxorubicin—ABCG2—nephron tubule—focal segmental glomerulosclerosis	0.000373	0.00474	CbGeAlD
Doxorubicin—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00037	0.00438	CcSEcCtD
Doxorubicin—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.000369	0.00437	CcSEcCtD
Doxorubicin—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.000366	0.00433	CcSEcCtD
Doxorubicin—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000366	0.00433	CcSEcCtD
Doxorubicin—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.000364	0.00431	CcSEcCtD
Doxorubicin—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000357	0.00423	CcSEcCtD
Doxorubicin—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.000351	0.00416	CcSEcCtD
Doxorubicin—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.000351	0.00416	CcSEcCtD
Doxorubicin—CYP2B6—nephron tubule—focal segmental glomerulosclerosis	0.000344	0.00437	CbGeAlD
Doxorubicin—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.000338	0.004	CcSEcCtD
Doxorubicin—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000335	0.00396	CcSEcCtD
Doxorubicin—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.000327	0.00387	CcSEcCtD
Doxorubicin—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.000326	0.00386	CcSEcCtD
Doxorubicin—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000323	0.00382	CcSEcCtD
Doxorubicin—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000316	0.00374	CcSEcCtD
Doxorubicin—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000315	0.00373	CcSEcCtD
Doxorubicin—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.000311	0.00368	CcSEcCtD
Doxorubicin—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.000309	0.00365	CcSEcCtD
Doxorubicin—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000303	0.00358	CcSEcCtD
Doxorubicin—CYP2B6—kidney—focal segmental glomerulosclerosis	0.000303	0.00384	CbGeAlD
Doxorubicin—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000297	0.00351	CcSEcCtD
Doxorubicin—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000289	0.00341	CcSEcCtD
Doxorubicin—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000287	0.00339	CcSEcCtD
Doxorubicin—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000285	0.00337	CcSEcCtD
Doxorubicin—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000281	0.00332	CcSEcCtD
Doxorubicin—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000279	0.0033	CcSEcCtD
Doxorubicin—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000278	0.00329	CcSEcCtD
Doxorubicin—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000277	0.00327	CcSEcCtD
Doxorubicin—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000275	0.00326	CcSEcCtD
Doxorubicin—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000275	0.00326	CcSEcCtD
Doxorubicin—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000271	0.0032	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00027	0.00319	CcSEcCtD
Doxorubicin—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000268	0.00317	CcSEcCtD
Doxorubicin—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000268	0.00317	CcSEcCtD
Doxorubicin—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000267	0.00316	CcSEcCtD
Doxorubicin—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000267	0.00316	CcSEcCtD
Doxorubicin—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000262	0.0031	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00026	0.00308	CcSEcCtD
Doxorubicin—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00026	0.00307	CcSEcCtD
Doxorubicin—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000258	0.00305	CcSEcCtD
Doxorubicin—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.000248	0.00294	CcSEcCtD
Doxorubicin—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000248	0.00293	CcSEcCtD
Doxorubicin—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000247	0.00292	CcSEcCtD
Doxorubicin—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000247	0.00292	CcSEcCtD
Doxorubicin—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000246	0.00291	CcSEcCtD
Doxorubicin—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000245	0.0029	CcSEcCtD
Doxorubicin—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000244	0.00289	CcSEcCtD
Doxorubicin—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000243	0.00287	CcSEcCtD
Doxorubicin—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000242	0.00287	CcSEcCtD
Doxorubicin—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000238	0.00282	CcSEcCtD
Doxorubicin—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00023	0.00273	CcSEcCtD
Doxorubicin—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000229	0.00271	CcSEcCtD
Doxorubicin—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000228	0.0029	CbGeAlD
Doxorubicin—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000225	0.00285	CbGeAlD
Doxorubicin—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000224	0.00265	CcSEcCtD
Doxorubicin—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000223	0.00263	CcSEcCtD
Doxorubicin—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000222	0.00262	CcSEcCtD
Doxorubicin—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000221	0.00261	CcSEcCtD
Doxorubicin—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000218	0.00258	CcSEcCtD
Doxorubicin—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000216	0.00256	CcSEcCtD
Doxorubicin—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000215	0.00254	CcSEcCtD
Doxorubicin—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000212	0.00251	CcSEcCtD
Doxorubicin—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000211	0.0025	CcSEcCtD
Doxorubicin—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000211	0.00249	CcSEcCtD
Doxorubicin—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000209	0.00247	CcSEcCtD
Doxorubicin—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000207	0.00245	CcSEcCtD
Doxorubicin—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000203	0.0024	CcSEcCtD
Doxorubicin—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0002	0.00236	CcSEcCtD
Doxorubicin—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000199	0.00235	CcSEcCtD
Doxorubicin—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000198	0.00234	CcSEcCtD
Doxorubicin—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000194	0.00229	CcSEcCtD
Doxorubicin—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000193	0.00229	CcSEcCtD
Doxorubicin—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000192	0.00228	CcSEcCtD
Doxorubicin—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000188	0.00222	CcSEcCtD
Doxorubicin—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000186	0.0022	CcSEcCtD
Doxorubicin—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000186	0.0022	CcSEcCtD
Doxorubicin—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000184	0.00234	CbGeAlD
Doxorubicin—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000183	0.00217	CcSEcCtD
Doxorubicin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000183	0.00217	CcSEcCtD
Doxorubicin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000183	0.00217	CcSEcCtD
Doxorubicin—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000182	0.00216	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000182	0.00215	CcSEcCtD
Doxorubicin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000181	0.00214	CcSEcCtD
Doxorubicin—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000179	0.00212	CcSEcCtD
Doxorubicin—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000177	0.00209	CcSEcCtD
Doxorubicin—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00208	CcSEcCtD
Doxorubicin—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00208	CcSEcCtD
Doxorubicin—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000174	0.00206	CcSEcCtD
Doxorubicin—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000172	0.00204	CcSEcCtD
Doxorubicin—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000172	0.00203	CcSEcCtD
Doxorubicin—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00017	0.00202	CcSEcCtD
Doxorubicin—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00017	0.00201	CcSEcCtD
Doxorubicin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000167	0.00198	CcSEcCtD
Doxorubicin—ABCB1—kidney—focal segmental glomerulosclerosis	0.000162	0.00205	CbGeAlD
Doxorubicin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00016	0.00189	CcSEcCtD
Doxorubicin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000159	0.00188	CcSEcCtD
Doxorubicin—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000158	0.00186	CcSEcCtD
Doxorubicin—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000157	0.002	CbGeAlD
Doxorubicin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000156	0.00185	CcSEcCtD
Doxorubicin—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000156	0.00185	CcSEcCtD
Doxorubicin—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000154	0.00183	CcSEcCtD
Doxorubicin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000153	0.00181	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000152	0.00179	CcSEcCtD
Doxorubicin—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000151	0.00179	CcSEcCtD
Doxorubicin—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00015	0.00178	CcSEcCtD
Doxorubicin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00015	0.00178	CcSEcCtD
Doxorubicin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000145	0.00171	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000144	0.0017	CcSEcCtD
Doxorubicin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000139	0.00165	CcSEcCtD
Doxorubicin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000139	0.00164	CcSEcCtD
Doxorubicin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000139	0.00164	CcSEcCtD
Doxorubicin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000129	0.00153	CcSEcCtD
Doxorubicin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000126	0.00149	CcSEcCtD
Doxorubicin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000124	0.00147	CcSEcCtD
Doxorubicin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00012	0.00142	CcSEcCtD
Doxorubicin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000116	0.00137	CcSEcCtD
Doxorubicin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000112	0.00132	CcSEcCtD
Doxorubicin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000111	0.00131	CcSEcCtD
Doxorubicin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000111	0.00131	CcSEcCtD
Doxorubicin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00011	0.0013	CcSEcCtD
Doxorubicin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000104	0.00123	CcSEcCtD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	6.83e-05	0.00161	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.81e-05	0.0016	CbGpPWpGaD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.69e-05	0.00157	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	6.65e-05	0.00157	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—GNAQ—focal segmental glomerulosclerosis	6.65e-05	0.00156	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	6.47e-05	0.00152	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—CTGF—focal segmental glomerulosclerosis	6.4e-05	0.00151	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—CTGF—focal segmental glomerulosclerosis	6.4e-05	0.00151	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.35e-05	0.0015	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	6.33e-05	0.00149	CbGpPWpGaD
Doxorubicin—NOS3—Corticotropin-releasing hormone—TGFB1—focal segmental glomerulosclerosis	6.3e-05	0.00148	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TRPC6—focal segmental glomerulosclerosis	6.17e-05	0.00145	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.08e-05	0.00143	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	6.04e-05	0.00142	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	6.03e-05	0.00142	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—CTGF—focal segmental glomerulosclerosis	6.02e-05	0.00142	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	5.92e-05	0.00139	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.9e-05	0.00139	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.9e-05	0.00139	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—LIPC—focal segmental glomerulosclerosis	5.81e-05	0.00137	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—PCNA—focal segmental glomerulosclerosis	5.66e-05	0.00133	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	5.59e-05	0.00131	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.54e-05	0.0013	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—LIPC—focal segmental glomerulosclerosis	5.42e-05	0.00128	CbGpPWpGaD
Doxorubicin—NQO1—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	5.34e-05	0.00126	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—FN1—focal segmental glomerulosclerosis	5.24e-05	0.00123	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	5.23e-05	0.00123	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—NOS2—focal segmental glomerulosclerosis	5.18e-05	0.00122	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—GNAQ—focal segmental glomerulosclerosis	5.16e-05	0.00121	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—CTGF—focal segmental glomerulosclerosis	5.12e-05	0.0012	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	5.07e-05	0.00119	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	5.07e-05	0.00119	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.87e-05	0.00115	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	4.79e-05	0.00113	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—CTGF—focal segmental glomerulosclerosis	4.77e-05	0.00112	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.71e-05	0.00111	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	4.7e-05	0.00111	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.7e-05	0.00111	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	4.51e-05	0.00106	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.5e-05	0.00106	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	4.48e-05	0.00106	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.47e-05	0.00105	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.44e-05	0.00105	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—LPL—focal segmental glomerulosclerosis	4.44e-05	0.00104	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—LPL—focal segmental glomerulosclerosis	4.44e-05	0.00104	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.43e-05	0.00104	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.4e-05	0.00103	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	4.36e-05	0.00103	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—ALB—focal segmental glomerulosclerosis	4.35e-05	0.00102	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	4.34e-05	0.00102	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—PCNA—focal segmental glomerulosclerosis	4.29e-05	0.00101	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.18e-05	0.000984	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—LPL—focal segmental glomerulosclerosis	4.17e-05	0.000981	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	4.16e-05	0.000978	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.14e-05	0.000973	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	3.99e-05	0.000938	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.97e-05	0.000933	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—FN1—focal segmental glomerulosclerosis	3.95e-05	0.00093	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—AGT—focal segmental glomerulosclerosis	3.79e-05	0.000893	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—AGT—focal segmental glomerulosclerosis	3.79e-05	0.000893	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	3.78e-05	0.000889	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.74e-05	0.000879	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	3.66e-05	0.000862	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.58e-05	0.000842	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—AGT—focal segmental glomerulosclerosis	3.57e-05	0.00084	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—LPL—focal segmental glomerulosclerosis	3.55e-05	0.000834	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.53e-05	0.00083	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.42e-05	0.000804	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.41e-05	0.000803	CbGpPWpGaD
Doxorubicin—ABCC3—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	3.39e-05	0.000797	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	3.37e-05	0.000793	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	3.37e-05	0.000793	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	3.35e-05	0.000789	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—LPL—focal segmental glomerulosclerosis	3.31e-05	0.000778	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.29e-05	0.000775	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	3.29e-05	0.000774	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—ALB—focal segmental glomerulosclerosis	3.28e-05	0.000772	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.26e-05	0.000766	CbGpPWpGaD
Doxorubicin—NOS1—Disease—LPL—focal segmental glomerulosclerosis	3.21e-05	0.000755	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.16e-05	0.000745	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.11e-05	0.000731	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	3.09e-05	0.000728	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—FN1—focal segmental glomerulosclerosis	3.07e-05	0.000722	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—LIPC—focal segmental glomerulosclerosis	3.05e-05	0.000718	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—AGT—focal segmental glomerulosclerosis	3.03e-05	0.000714	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—NOS2—focal segmental glomerulosclerosis	3.03e-05	0.000714	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3e-05	0.000707	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—PCNA—focal segmental glomerulosclerosis	3e-05	0.000706	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—ALB—focal segmental glomerulosclerosis	2.91e-05	0.000685	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—ALB—focal segmental glomerulosclerosis	2.91e-05	0.000685	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.9e-05	0.000682	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.87e-05	0.000675	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.87e-05	0.000674	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	2.85e-05	0.00067	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—LIPC—focal segmental glomerulosclerosis	2.84e-05	0.000668	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—AGT—focal segmental glomerulosclerosis	2.83e-05	0.000666	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.81e-05	0.000661	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.79e-05	0.000656	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.75e-05	0.000648	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.75e-05	0.000647	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.75e-05	0.000646	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—ALB—focal segmental glomerulosclerosis	2.74e-05	0.000644	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CTGF—focal segmental glomerulosclerosis	2.69e-05	0.000632	CbGpPWpGaD
Doxorubicin—ABCC2—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	2.69e-05	0.000632	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.66e-05	0.000627	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—LIPC—focal segmental glomerulosclerosis	2.58e-05	0.000607	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.57e-05	0.000604	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	2.55e-05	0.000601	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—ALB—focal segmental glomerulosclerosis	2.55e-05	0.0006	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NOS2—focal segmental glomerulosclerosis	2.51e-05	0.00059	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CTGF—focal segmental glomerulosclerosis	2.5e-05	0.000588	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.48e-05	0.000583	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.48e-05	0.000583	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.46e-05	0.00058	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.45e-05	0.000577	CbGpPWpGaD
Doxorubicin—NOS2—Disease—LPL—focal segmental glomerulosclerosis	2.42e-05	0.00057	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.4e-05	0.000566	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.35e-05	0.000553	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—ALB—focal segmental glomerulosclerosis	2.33e-05	0.000548	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.3e-05	0.000542	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	2.28e-05	0.000537	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CTGF—focal segmental glomerulosclerosis	2.27e-05	0.000534	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—LPL—focal segmental glomerulosclerosis	2.22e-05	0.000523	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.22e-05	0.000523	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—ALB—focal segmental glomerulosclerosis	2.17e-05	0.000511	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.15e-05	0.000507	CbGpPWpGaD
Doxorubicin—NOS1—Disease—SERPINE1—focal segmental glomerulosclerosis	2.11e-05	0.000497	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.09e-05	0.000492	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—LIPC—focal segmental glomerulosclerosis	2.09e-05	0.000492	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.09e-05	0.000492	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.08e-05	0.00049	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.08e-05	0.00049	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.08e-05	0.000489	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.07e-05	0.000487	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	2.06e-05	0.000486	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—LIPC—focal segmental glomerulosclerosis	2.01e-05	0.000472	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—LPL—focal segmental glomerulosclerosis	1.93e-05	0.000454	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.89e-05	0.000446	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.88e-05	0.000443	CbGpPWpGaD
Doxorubicin—NOS3—Disease—LPL—focal segmental glomerulosclerosis	1.88e-05	0.000442	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—LPL—focal segmental glomerulosclerosis	1.86e-05	0.000438	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.85e-05	0.000435	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.84e-05	0.000434	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CTGF—focal segmental glomerulosclerosis	1.84e-05	0.000433	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.8e-05	0.000425	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.78e-05	0.000419	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CTGF—focal segmental glomerulosclerosis	1.77e-05	0.000416	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.75e-05	0.000412	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NOS2—focal segmental glomerulosclerosis	1.74e-05	0.000409	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—LPL—focal segmental glomerulosclerosis	1.73e-05	0.000408	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.72e-05	0.000404	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.7e-05	0.000399	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AGT—focal segmental glomerulosclerosis	1.65e-05	0.000389	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.63e-05	0.000383	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TGFB1—focal segmental glomerulosclerosis	1.61e-05	0.000379	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.61e-05	0.000378	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.6e-05	0.000377	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AGT—focal segmental glomerulosclerosis	1.59e-05	0.000375	CbGpPWpGaD
Doxorubicin—NOS2—Disease—SERPINE1—focal segmental glomerulosclerosis	1.59e-05	0.000375	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—LPL—focal segmental glomerulosclerosis	1.57e-05	0.00037	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.57e-05	0.00037	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.56e-05	0.000367	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.55e-05	0.000365	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.52e-05	0.000358	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AGT—focal segmental glomerulosclerosis	1.48e-05	0.000349	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.48e-05	0.000347	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NOS2—focal segmental glomerulosclerosis	1.47e-05	0.000345	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—SERPINE1—focal segmental glomerulosclerosis	1.46e-05	0.000344	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.42e-05	0.000333	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.41e-05	0.000333	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.38e-05	0.000326	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.38e-05	0.000325	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.37e-05	0.000322	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.36e-05	0.00032	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.36e-05	0.000319	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AGT—focal segmental glomerulosclerosis	1.35e-05	0.000317	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.34e-05	0.000316	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.34e-05	0.000315	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.33e-05	0.000314	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TGFB1—focal segmental glomerulosclerosis	1.33e-05	0.000314	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.32e-05	0.00031	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—LPL—focal segmental glomerulosclerosis	1.28e-05	0.0003	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.27e-05	0.0003	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ALB—focal segmental glomerulosclerosis	1.27e-05	0.000298	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.25e-05	0.000293	CbGpPWpGaD
Doxorubicin—NOS3—Disease—SERPINE1—focal segmental glomerulosclerosis	1.24e-05	0.000291	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.23e-05	0.00029	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.23e-05	0.00029	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—LPL—focal segmental glomerulosclerosis	1.22e-05	0.000288	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ALB—focal segmental glomerulosclerosis	1.22e-05	0.000288	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.22e-05	0.000287	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.18e-05	0.000278	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.17e-05	0.000275	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—LPL—focal segmental glomerulosclerosis	1.15e-05	0.00027	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ALB—focal segmental glomerulosclerosis	1.14e-05	0.000268	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.13e-05	0.000265	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.12e-05	0.000264	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AGT—focal segmental glomerulosclerosis	1.09e-05	0.000257	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AGT—focal segmental glomerulosclerosis	1.05e-05	0.000246	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.04e-05	0.000245	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ALB—focal segmental glomerulosclerosis	1.03e-05	0.000243	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.02e-05	0.000241	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	1.02e-05	0.00024	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—LIPC—focal segmental glomerulosclerosis	1.01e-05	0.000239	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TGFB1—focal segmental glomerulosclerosis	1.01e-05	0.000237	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—LPL—focal segmental glomerulosclerosis	9.59e-06	0.000226	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—LPL—focal segmental glomerulosclerosis	9.28e-06	0.000218	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TGFB1—focal segmental glomerulosclerosis	9.24e-06	0.000217	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS2—focal segmental glomerulosclerosis	8.94e-06	0.000211	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CTGF—focal segmental glomerulosclerosis	8.92e-06	0.00021	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.66e-06	0.000204	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—LPL—focal segmental glomerulosclerosis	8.44e-06	0.000199	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ALB—focal segmental glomerulosclerosis	8.38e-06	0.000197	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.22e-06	0.000194	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AGT—focal segmental glomerulosclerosis	8.2e-06	0.000193	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ALB—focal segmental glomerulosclerosis	8.04e-06	0.000189	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AGT—focal segmental glomerulosclerosis	7.94e-06	0.000187	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.85e-06	0.000185	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TGFB1—focal segmental glomerulosclerosis	7.8e-06	0.000184	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SERPINE1—focal segmental glomerulosclerosis	7.53e-06	0.000177	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	7.48e-06	0.000176	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AGT—focal segmental glomerulosclerosis	7.22e-06	0.00017	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	7.05e-06	0.000166	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.63e-06	0.000156	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	6.58e-06	0.000155	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.47e-06	0.000152	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.4e-06	0.000151	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—focal segmental glomerulosclerosis	6.3e-06	0.000148	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	6.2e-06	0.000146	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—LPL—focal segmental glomerulosclerosis	6.19e-06	0.000146	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—focal segmental glomerulosclerosis	6.09e-06	0.000143	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.06e-06	0.000143	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.72e-06	0.000134	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—focal segmental glomerulosclerosis	5.54e-06	0.00013	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.46e-06	0.000129	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AGT—focal segmental glomerulosclerosis	5.29e-06	0.000125	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—focal segmental glomerulosclerosis	4.76e-06	0.000112	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	4.61e-06	0.000108	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	4.56e-06	0.000107	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	4.3e-06	0.000101	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—focal segmental glomerulosclerosis	4.06e-06	9.56e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	4.06e-06	9.54e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	3.9e-06	9.19e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.74e-06	8.79e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	3.68e-06	8.66e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	3e-06	7.05e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	2.82e-06	6.64e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	2.81e-06	6.62e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.4e-06	5.66e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.85e-06	4.34e-05	CbGpPWpGaD
